Drug Shortage Report for HYDRALAZINE HYDROCHLORIDE INJECTION, USP
| Report ID | 221285 |
| Drug Identification Number | 02516160 |
| Brand name | HYDRALAZINE HYDROCHLORIDE INJECTION, USP |
| Common or Proper name | HYDRALAZINE HYDROCHLORIDE INJECTION, USP |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDRALAZINE HYDROCHLORIDE |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1ML |
| ATC code | C02DB |
| ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-04 |
| Estimated end date | 2024-04-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-03-05 | English | Compare |
| v2 | 2024-03-04 | French | Compare |
| v1 | 2024-03-04 | English | Compare |
Showing 1 to 3 of 3